VAERS reports by lot

GSK Varicella/Shingles lot M77B4: VAERS reports

91 VAERS reports list lot M77B4 as a GSK Varicella/Shingles vaccine, received between 2018-08-02 and 2019-10-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
91
Reports
3%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)9526%
Injection-site / Local reaction9025%
Neurological4412%
Musculoskeletal3610%
Dermatological (non-injection-site)288%
Gastrointestinal236%
Allergic / Anaphylactic195%
Cardiac / Cardiovascular164%
Psychiatric / Neuropsychiatric51%
Respiratory41%
Thrombotic / Hematological21%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York12
Pennsylvania8
Florida6
Maryland5
North Carolina5
Massachusetts4
Iowa4
Kansas4
Missouri4
Colorado4
Nevada4
Indiana3

Reports by month received

2018-0848
2018-0916
2018-1010
2018-116
2018-121
2019-012
2019-021
2019-031
2019-042
2019-061
2019-071
2019-081
2019-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.